Gaurav Maini
Stock Analyst at LifeSci Capital
(0.11)
# 4,704
Out of 5,036 analysts
51
Total ratings
20%
Success rate
-30%
Average return
Main Sectors:
Stocks Rated by Gaurav Maini
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LQDA Liquidia | Reiterated: Hold | n/a | $26.68 | - | 7 | Sep 30, 2026 | |
| CTNM Contineum Therapeutics | Reiterated: Buy | $23 | $12.73 | +80.68% | 4 | Sep 29, 2026 | |
| TECX Tectonic Therapeutic | Reiterated: Buy | $88 | $22.71 | +287.49% | 10 | Sep 29, 2026 | |
| SION Sionna Therapeutics | Reiterated: Hold | $6 | $4.82 | +24.48% | 14 | Sep 19, 2026 | |
| IKT Inhibikase Therapeutics | Reiterated: Buy | $5 | $1.94 | +157.73% | 6 | Sep 15, 2026 | |
| TENX Tenax Therapeutics | Reiterated: Buy | $35 → $5 | $1.91 | +161.78% | 9 | Aug 10, 2026 | |
| CNTM ConnectM Technology Solutions, Inc. | Initiated Coverage: Buy | $24 | $4.20 | +471.43% | 1 | Jul 30, 2026 |
Liquidia
Sep 30, 2026
Reiterated: Hold
Price Target: n/a
Current: $26.68
Upside: -
Contineum Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $23
Current: $12.73
Upside: +80.68%
Tectonic Therapeutic
Sep 29, 2026
Reiterated: Buy
Price Target: $88
Current: $22.71
Upside: +287.49%
Sionna Therapeutics
Sep 19, 2026
Reiterated: Hold
Price Target: $6
Current: $4.82
Upside: +24.48%
Inhibikase Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $5
Current: $1.94
Upside: +157.73%
Tenax Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $35 → $5
Current: $1.91
Upside: +161.78%
ConnectM Technology Solutions, Inc.
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $4.20
Upside: +471.43%